BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 13427633)

  • 1. The mechanism of action of the sulfonylureas in diabetes mellitus.
    LEVINE R; SOBEL GW
    Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
    DAVIDSON JW; UNGER RH
    J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfonylureas and diabetes mellitus. I. Clinical evaluation.
    COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the mechanism of action of sulfonylurea derivatives.
    GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
    Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
    COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
    J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations with sulfonylureas in diabetes.
    BROWN FR; FRISKEY RW; KINSELL LW; MICHAELS GD
    Metabolism; 1956 Nov; 5(6 Part 2):864-7. PubMed ID: 13378055
    [No Abstract]   [Full Text] [Related]  

  • 7. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference.
    KRAHL ME; LUKENS FD; RICKETTS HT
    Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436
    [No Abstract]   [Full Text] [Related]  

  • 8. The hypoglucemic sulfonylurea drugs; an interim evaluation.
    STETTEN D
    Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].
    BERTRAM F
    Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations in diabetic subjects treated with sulfonylurea compounds.
    BROWN F; FRISKEY R; KINSELL LW; SPLITTER TS; TALPERS SJ
    Diabetes; 1957; 6(1):64-7; discussion, 85-90. PubMed ID: 13397428
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies on the hypoglycaemic action of the sulphonylureas.
    BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
    Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of sulfonylurea drugs in hospitalized diabetic patients.
    RICKETTS HT; WILDBERGER HL
    Diabetes; 1957; 6(1):62-4; discussion, 85-90. PubMed ID: 13397427
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of sulfonylurea drugs in hospitalized diabetic patients.
    RICKETTS HT; WILDBERGER HL
    J Am Med Assoc; 1956 Nov; 162(11):1045-9. PubMed ID: 13366706
    [No Abstract]   [Full Text] [Related]  

  • 14. Methods of selection of diabetic patients sensitive to sulfonylurea compounds.
    DUNCAN GG; JOINER CL; LEE CT
    Metabolism; 1956 Nov; 5(6 Part 2):964-71. PubMed ID: 13378066
    [No Abstract]   [Full Text] [Related]  

  • 15. CURRENT investigation of the hypoglycemic action of sulfonylureas.
    Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of oral sulfonylurea compounds in diabetes mellitus.
    COLWELL AR; COLWELL JA
    Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfonylureas and diabetes mellitus. II. Preliminary studies of the mechanism of action.
    COX RW; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):366-77. PubMed ID: 13365476
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolbutamide in treatment of diabetes mellitus.
    BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE
    Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469
    [No Abstract]   [Full Text] [Related]  

  • 19. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of sulfonylurea compounds in diabetic children.
    Camerini-Davalos R; Marble A; White P; Belmonte M; Sargeant L
    N Engl J Med; 1957 May; 256(18):817-22. PubMed ID: 13451946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.